glp 1 overweight GLP-1 Agonists In Obesity Obesity treatment and the rise

A Brief History of GLP-1 Agonists First approved to treat diabetes under the brand name Ozempic, semaglutide (Novo Nordisk) received a U.S

Glucagon secretion is reciprocally inhibited by insulin action

Appetite suppression is so strong that many people are eating 900-1,200 total calories a day without trying to, and protein is often the first thing to fall short because it requires more deliberate meal planning than simply eating less of everything

Morphological studies revealed that the neurons in the bed nucleus of the stria terminalis (BNST) express a high level of GLP-1R (Cork et al., 2015

Appl Environ Microbiol 76(9):30483051

Weekly injections, ongoing monitoring, and the need to manage side effects can become burdensome over time